C
Cerus Corporation
CERS · NASDAQ · Healthcare · 601M
Price · close
$2.81
+0.72% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
8.2×
Enterprise value / EBITDAEV/EBITDA
-111.1×
Free cash flow yieldFCF yield
1.6%
Return on equityROE
-24.3%
Operating margin
-4.2%
Net debt / EBITDAbalance-sheet strength
-14.0×
Interest coverage
-1.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.